Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Cardiol Therapeutics Inc. logo — Life sciences company focused on the research and clinical d...

Cardiol Therapeutics Inc.

Life sciences company focused on the research and clinical development of therapies for the treatment of heart disease

Founded 2017 Canada Canada 27 employees Post Ipo Equity Total: $78.62M Biotechnology, Life Sciences

General Information

Company Name Cardiol Therapeutics Inc.
Founded Year 2017
Location Canada Canada +1
Employees 27
Industries Biotechnology, Life Sciences
Funding Stage Post Ipo Equity
Social

Get notified when Cardiol Therapeutics Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Cardiol Therapeutics Inc.

Cardiol Therapeutics is a biotechnology startup founded in 2017 that is pioneering advanced cannabidiol solutions and heart disease treatments for a healthier future. The company specializes in creating pharmaceutical cannabidiol products and pioneering treatments for heart conditions, including acute myocarditis and various heart failure causes. Cardiol Therapeutics leverages its proficiency in pharmaceutical cannabinoids to craft unique formulations aimed at two crucial medical markets. This includes developing a range of pharmaceutical cannabidiol products for the expanding medical cannabinoids sector and creating nanotechnologies intended to deliver cannabinoids and other anti-inflammatory medications to the heart to address inflammatory heart diseases. At $50.19M, Cardiol Therapeutics received a Post-IPO Equity investment on 03 November 2021. The specific investors contributing to this investment are not disclosed.

Taxonomy: pharmaceutical cannabinoids, cannabidiol products, heart disease treatments, acute myocarditis, heart failure, nanotechnologies, medical cannabinoids sector, anti-inflammatory medications, proprietary formulations, commercial development, medical cannabinoids market, innovative therapies, nanotechnologies for drug delivery, inflammatory heart disease, pharmaceutical development

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 03 Nov 2021
Post-IPO Equity •••••• 4
Investor Investor Investor Investor
13 May 2020
Convertible Note •••••• - 24 May 2018
Seed Round •••••• - 29 Sep 2017

FAQ About Cardiol Therapeutics Inc.

Life sciences company focused on the research and clinical development of therapies for the treatment of heart disease
Cardiol Therapeutics Inc. was founded in 2017.
Cardiol Therapeutics Inc. is headquartered in Canada.
Cardiol Therapeutics Inc. operates in the following industries: Biotechnology, Life Sciences.
Cardiol Therapeutics Inc. has approximately 27 employees.
Cardiol Therapeutics Inc. has completed 4 funding rounds, raising a total of $78.62M. The latest funding stage is Post Ipo Equity.

We're actively collecting intelligence on Cardiol Therapeutics Inc. .

Track Cardiol Therapeutics Inc. to get notified

Don't just browse. Track.

Signal Tracker monitors Cardiol Therapeutics Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy